Oh damn, this will be the coming Wed, in 3 more sleeps.
Merck is talking to Australia directly with licensing/partnering activities. Tell me there is nothing to do with eftilagimod.
And look at the reply in below, directly from their licensing team from the oncology branch.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
24.5¢ |
Change
-0.010(3.92%) |
Mkt cap ! $359.6M | |||
| Open | High | Low | Value | Volume |
| 25.5¢ | 26.0¢ | 24.0¢ | $1.197M | 4.863M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 23 | 303947 | 24.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 25.0¢ | 101249 | 17 |
View Market Depth
| Last trade - 14.10pm 23/07/2025 (20 minute delay) ? |
| IMM (ASX) Chart |